Clinical trial
Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone…
NCT00434447 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00434447 |
|---|---|
| Title | Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases |
| Official title | A Phase IV Study of Zoledronic Acid Therapy in Patients With Bone Metastases From Breast Cancer or Hormone Resistant Prostate Cancer, or Bone Involvement From Multiple Myeloma, Assessing Long-term Efficacy and Safety |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bone Neoplasms |
| Intervention type | Drug |
| Interventions | Zoledronic acid |
| Enrollment | 73 |
| Start date | Dec 1, 2006 |
| Primary completion | Sep 1, 2009 |
| First posted | Feb 13, 2007 |
| Last update posted | Feb 27, 2017 |
| Countries | Australia |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: